During the past decade, Carolina Oncology Specialists, PA - Hickory conducted 2 clinical trials. In the 10-year time frame, 2 clinical trials started and 13 clinical trials were completed, i.e. on average, 650% percent of trials that started reached the finish line to date. In the past 5 years, 0 clinical trials started and 4 clinical trials were completed. i.e. 0% of trials that started reached the finish line.

Out of the total clinical trials conducted in "Carolina Oncology Specialists, PA - Hickory" #1 sponsor was "Hoffmann-La Roche" with 6 trials, followed by "Genentech, Inc." with 4 trials sponsored, "Novartis Pharmaceuticals" with 3 trials sponsored, "Amgen" with 2 trials sponsored and "Celgene" with 2 trials sponsored. Other sponsors include 8 different institutions and companies that sponsored additional 16 trials in total.

In terms of collaborators to trials, out of the total clinical trials conducted in "Carolina Oncology Specialists, PA - Hickory" #1 collaborator was "Genentech, Inc." with 3 trials as a collaborator, "Hoffmann-La Roche" with 3 trials as a collaborator, "Breast International Group" with 1 trials as a collaborator, "Cancer International Research Group (CIRG)" with 1 trials as a collaborator and "Celgene Corporation" with 1 trials as a collaborator. Other collaborators include -3 different institutions and companies that were collaborators in the rest 7 trials.

According to Clinical.Site data, the most researched conditions in "Carolina Oncology Specialists, PA - Hickory" are "Breast Cancer" (5 trials), "Lung Cancer" (2 trials), "Multiple Myeloma" (2 trials), "Non-Small Cell Lung Cancer" (2 trials) and "Non-Squamous Non-Small Cell Lung Cancer" (2 trials). Many other conditions were trialed in "Carolina Oncology Specialists, PA - Hickory" in a lesser frequency.

Most popular intervention types in "Carolina Oncology Specialists, PA - Hickory" are "Drug" (29 trials), "Biological" (2 trials) and "Procedure" (1 trials). Other intervention types were less common.

The name of intervention was led by "Docetaxel" (6 trials), "Placebo" (4 trials), "Trastuzumab" (4 trials), "Carboplatin" (3 trials) and "Pertuzumab" (3 trials). Other intervention names were less common.

The vast majority of trials in "Carolina Oncology Specialists, PA - Hickory" are 25 trials for "All" genders, 3 trials for "Female" genders and 2 trials for "Male" genders.

Currently, there are NaN active trials in "Carolina Oncology Specialists, PA - Hickory". undefined are not yet recruiting, 1 are recruiting, 2 are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 19 completed trials in Carolina Oncology Specialists, PA - Hickory, undefined suspended trials, and 6 terminated clinical trials to date.

Out of the total trials that were conducted in Carolina Oncology Specialists, PA - Hickory, 0 "Phase 1" clinical trials were conducted, 13 "Phase 2" clinical trials and 15 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 1 trials, and there were also 0 trials that are defined as “Not Applicable".